Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company in the United States dedicated to developing novel therapeutics. Its purpose is to address diverse medical conditions, including central nervous system disorders and rare diseases, to significantly improve patient outcomes. Operating within the biotechnology sector, Tonix Pharmaceuticals Holding Corp focuses on advancing its clinical-stage drug candidates. Its approach involves innovative research to develop treatments intended to meet significant unmet medical needs in areas such as neuropsychiatry and immunology. Stay up to date on the share price of TNXP by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.